docAmbrisentan Improves Exercise Capacity and Symptoms in Patients
download 
Stížnost Podobné dokumenty
Pulmonary Hypertension in Chronic Lung Diseases
has a survival range of only 2.5 to 3.5 years, mPAP values of
>25 mm Hg were reported in 8.1% and 14.9% of patients,
respectively, upon initial workup (9,10). Higher percentages
are found in advanc...
